AzTrials
AzTrials

DepressionEarly Phase 1NCT00737399

Anxiety and Depression Levels in Cancer Patients After Self-Application of EFT (Emotional Freedom Techniques)

A Early Phase 1 study testing Lifestyle Counseling with Emotional Freedom Techniques (EFT) in people with Depression, run by Soul Medicine Institute at 1 site in United States.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Anxiety and depression have been found to be significant co-occurring conditions in cancer patients. This study examines these and other psychological conditions in patients diagnosed with cholangiocarcinoma, a rare cancer of the bile duct, with an average survival time of three to six months post-diagnosis. Read more about this study

Who is it for?
Ages 18 to 89 years
Conditions the study is for
Depression
What is being tested?
Lifestyle Counseling with Emotional Freedom Techniques (EFT)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
14 participants
Where
1 siteUnited States
Study dates
20 Sep 2008to 25 Dec 2028
Phase
Early Phase 1
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 89 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Diagnosis of cholangiocarcinoma
  • Ability to complete forms and attend phone coaching sessions

Who cannot join

  • None

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Soul Medicine Institute

    Santa Rosa, California, 95403

Other trials in United States

About this study

Anxiety and depression have been found to be significant co-occurring conditions in cancer patients. This study examines these and other psychological conditions in patients diagnosed with cholangiocarcinoma, a rare cancer of the bile duct, with an average survival time of three to six months post-diagnosis. Participants are taught EFT in telephone and internet group coaching sessions, and have access to an online support forum. They complete the Mini-Mental Adjustment to Cancer Scale (Mini-MAC), EORTC Quality of Life scale, the PTSD checklist, the Patient Health Questionnaire, and a brief health checklist. Participants also provide medical records confirming their diagnosis, and markers, both before and after the study. The study is expected to enroll 20-15 cholangiocarcinoma patients, and use a within-subjects, time series, repeated measures design. Symptoms are assessed prior to coaching, after four, and again after eight weekly coaching sessions. Follow-ups will occur in one month, three months, and one year. It is hypothesized that a drop in the severity of co-occurring psychological symptoms, pain and insomnia may occur after EFT coaching.

Conditions
Depression
Being tested
Lifestyle Counseling with Emotional Freedom Techniques (EFT)
Keywords
depression, anxiety, pain, insomnia, cancer, cholangiocarcinoma, EFT (Emotional Freedom Techniques)
Medical subject headings
Depression, Anxiety Disorders, Pain, Sleep Initiation and Maintenance Disorders, Neoplasms, Cholangiocarcinoma

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Lifestyle Counseling with Emotional Freedom Techniques (EFT)Behavioural

    Two series of four sessions of phone support group coaching instruction in the use of EFT

Study groups in NCT00737399
Study groupRoleWhat they receive
1ExperimentalLifestyle Counseling with Emotional Freedom Techniques (EFT)
Receives: Behavioral: Lifestyle Counseling with Emotional Freedom Techniques (EFT)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. depression

    Measured: duration of study

Secondary outcomes (3)
  1. anxiety

    Measured: duration of study

  2. pain

    Measured: duration of study

  3. insomnia

    Measured: duration of study

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Aug 2008 (estimated)
  2. Study start20 Sep 2008
  3. Primary completion23 Apr 2028 (estimated)
  4. Study completion25 Dec 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Early Phase 1
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
14 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00737399
Sponsor's protocol ID
SMI-CHOL-82008
Status last verified
Apr 2026
First submitted
18 Aug 2008
Last updated
27 Apr 2026
Results posted
No
Data monitoring committee
No

Publications

  • Endo I, Gonen M, Yopp AC, Dalal KM, Zhou Q, Klimstra D, D'Angelica M, DeMatteo RP, Fong Y, Schwartz L, Kemeny N, O'Reilly E, Abou-Alfa GK, Shimada H, Blumgart LH, Jarnagin WR. Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg. 2008 Jul;248(1):84-96. doi: 10.1097/SLA.0b013e318176c4d3.

    PubMed 18580211

Questions about this trial

What is this clinical trial studying?

A Early Phase 1 study testing Lifestyle Counseling with Emotional Freedom Techniques (EFT) in people with Depression, run by Soul Medicine Institute at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 27 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Early Phase 1 (sometimes called Phase 0) studies give a very small amount of a treatment to a few people, mainly to see how the body handles it.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

depression (time frame: duration of study). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00737399, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in